The First International Symposium on Pheochromocytoma, held in October 2005, included discussions about developments concerning these rare catecholamine-producing tumors. Recommendations were made ...

Results from the trial will be presented at an upcoming medical meeting. “Pheochromocytoma and paraganglioma are rare tumors that form in and around the adrenal glands, and currently, there are no ...

Surgical resection of pheochromocytoma is associated with a high risk of intraoperative hemodynamic instability owing to abrupt changes in tumoral catecholamine secretion. A study by Bruynzeel et al.

A metaiodobenzylguanidine scan showed positive uptake within the mass, which supported a diagnosis of pheochromocytoma. The patient underwent a laparoscopic right suprarenal adrenalectomy after ...

A pheochromocytoma tumor, which Kanellis was diagnosed with, causes uncontrolled bursts of adrenaline which affects several vitals such as blood pressure and heart rate. Kanellis went through with ...

Low-osmolar, contrast-enhanced CT can be safely used in patients with pheochromocytoma. “This tool will enhance physicians' abilities to diagnose and treat patients with pheochromocytoma ...

The FDA has set a Prescription Drug User Fee Act (PDUFA), or target action, date of May 26, 2025. “Pheochromocytoma and paraganglioma are rare tumours that form in and around the adrenal glands, and ...

Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in patients with advanced, unresectable, or metastatic pheochromocytoma and ...

Monitor HR during therapy. Bronchospastic disease. Pheochromocytoma. Surgery. Diabetes. May mask signs and increase risk for hypoglycemia. Hyperthyroidism. Avoid abrupt cessation. Hepatic impairment.